Results 41 to 50 of about 91,972 (285)

Audio-vestibular symptoms in systemic autoimmune diseases [PDF]

open access: yes, 2018
Immune-mediated inner ear disease can be primary, when the autoimmune response is against the inner ear, or secondary. The latter is characterized by the involvement of the ear in the presence of systemic autoimmune conditions. Sensorineural hearing loss
Adelchi, Croce   +7 more
core   +1 more source

Myasthenia Gravis [PDF]

open access: yesNew England Journal of Medicine, 1978
The basic abnormality in myasthenia gravis (MG) is a reduction in acetylcholine receptors (AChRs) at neuromuscular junctions due to the effects of autoantibodies that are directed against the AChRs in most patients, or against neighboring proteins involved in the clustering of AChRs (MuSK, LRP-4, or agrin).
openaire   +5 more sources

MYASTHENIA GRAVIS [PDF]

open access: yesBrain, 1900
n ...
Campbell, Harry, Bramwell, Edwin
openaire   +2 more sources

Immune Checkpoint Inhibitor-Induced Myasthenia Gravis

open access: yesFrontiers in Neurology, 2020
The development of immune checkpoint inhibitors (ICIs) has been a major breakthrough in cancer immunotherapy. The increasing use of ICIs has led to the discovery of a broad spectrum of immune-related adverse events (irAEs).
Yi-Te Huang   +4 more
semanticscholar   +1 more source

Pyridostigmine in pediatric Intestinal pseudo-obstruction. case report of a 2-year old girl and literature review [PDF]

open access: yes, 2019
Pediatric chronic intestinal pseudo-obstruction is a rare disorder characterized by a severe impairment of gastrointestinal motility leading to intestinal obstruction symptoms in the absence of mechanical causes.
Caló, Girolamo   +8 more
core   +2 more sources

Myasthenia gravis

open access: yesThe Lancet, 2001
Myasthenia gravis is an autoimmune disorder mainly caused by antibodies to the muscle acetylcholine receptors (AChRs) at the neuromuscular junction. Loss of these receptors leads to a defect in neuromuscular transmission with muscle weakness and fatigue.
Vincent, A, Palace, J, Hilton-Jones, D
openaire   +2 more sources

Docetaxel/cisplatin therapy in myasthenia gravis with hypertension/diabetes

open access: yesOpen Medicine, 2017
Therapeutic options for thymoma-associated myasthenia gravis (MG) patients complicated with hypertension and/or diabetes post thymectomy are often conventional steroids. As the prevalence of diabetes and hypertension globally increases, other therapeutic
Qi Guoyan   +4 more
doaj   +1 more source

Characteristic and Correlation Between TIME and Complication After Destructive Eye Procedure Patient at Plastic and Reconstruction Division Sanglah Hospital\u27s Eye Clinic Bali-Indonesia [PDF]

open access: yes, 2012
Destructive eye procedure can be carried out by enucleation, evisceration and excenteration. Some efforts have been developed to reduce the complications, but it still occur within several years after the operation.
Sukartini, D. (D)   +2 more
core   +2 more sources

COVID‐19 in patients with myasthenia gravis

open access: yesMuscle and Nerve, 2020
Coronavirus disease 2019 (COVID‐19) has rapidly become a global pandemic, but little is known about its potential impact on patients with myasthenia gravis (MG).
Pria Anand   +7 more
semanticscholar   +1 more source

Causal relationship between gut microbiota and myasthenia gravis: a bidirectional mendelian randomization study

open access: yesCell & Bioscience, 2023
Background Observational studies have demonstrated an association between gut microbiota and myasthenia gravis; however, the causal relationship between the two still lacks clarity.
Tengfei Su   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy